Ursodeoxycholic acid in neonatal sepsis-associated cholestasis
Background Sepsis-associated cholestasis (SAC) is an intrahepatic cholestasis caused by inflammatory cytokines. Patients with this condition have poor prognoses. Antibiotics are the mainstay of therapy, however, other adjuvant therapies, such as ursodeoxycholic acid (UDCA), have not been well establ...
Saved in:
Main Authors: | Rita Mey Rina (Author), Hanifah Oswari (Author), Pustika Amalia (Author) |
---|---|
Format: | Book |
Published: |
Indonesian Pediatric Society Publishing House,
2014-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ursodeoxycholic acid versus phenobarbital for cholestasis in the Neonatal Intensive Care Unit
by: Tamorah Lewis, et al.
Published: (2018) -
Pilot study for a trial of ursodeoxycholic acid and/or early delivery for obstetric cholestasis
by: Briley Annette, et al.
Published: (2009) -
Role of ursodeoxycholic acid in neonatal indirect hyperbilirubinemia: a systematic review and meta-analysis of randomized controlled trials
by: Glen Lazarus, et al.
Published: (2022) -
Rationale, completeness and quality of evidence for the use of ursodeoxycholic acid in neonatal hyperbilirubinemia
by: Olesya V. Zakharova
Published: (2024) -
A Clinical & Experimental Obstetrics and Gynecology survey on ursodeoxycholic treatment of intrahepatic cholestasis of pregnancy: scholars' opinion
by: Caroline Ovadia, et al.
Published: (2021)